Time for Resolution of COVID-19 Vaccine-Related Axillary Lymphadenopathy and Associated Factors

Article Radiology, Nuclear Medicine & Medical Imaging

COVID-19 Vaccine-Associated Subclinical Axillary Lymphadenopathy on Screening Mammogram

Sean Raj et al.

Summary: Women who received a COVID-19 vaccination before screening mammography were significantly more likely to present with subclinical axillary lymphadenopathy compared to women who did not receive the vaccine.

ACADEMIC RADIOLOGY (2022)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

Axillary Adenopathy after COVID-19 Vaccine: No Reason to Delay Screening Mammogram

Stacey Wolfson et al.

RADIOLOGY (2022)

Add to Collection

Article Medicine, General & Internal

Axillary Lymphadenopathy on Ultrasound after COVID-19 Vaccination and Its Influencing Factors: A Single-Center Study

Ji Yeon Park et al.

Summary: This study aimed to assess the incidence of axillary lymphadenopathy on ultrasound after COVID-19 vaccination and identified factors affecting lymphadenopathy. The results showed that mRNA vaccine type, interval from vaccination, younger age, and first dose were important factors contributing to axillary lymphadenopathy. Breast clinicians should be aware of these side effects and provide accurate information to patients during imaging examinations.

JOURNAL OF CLINICAL MEDICINE (2022)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

Axillary lymphadenopathy at the time of COVID-19 vaccination: ten recommendations from the European Society of Breast Imaging (EUSOBI)

Simone Schiaffino et al.

Summary: Unilateral axillary lymphadenopathy is a common side effect of COVID-19 vaccination, and the European Society of Breast Imaging has proposed ten recommendations to standardize its management and reduce unnecessary procedures, emphasizing the importance of individualized assessment and appropriate imaging techniques.

INSIGHTS INTO IMAGING (2021)

Add to Collection

Editorial Material Radiology, Nuclear Medicine & Medical Imaging

COVID-19 Vaccination-Associated Axillary Adenopathy: Imaging Findings and Follow-Up Recommendations in 23 Women

Shabnam Mortazavi

Summary: This article reports on 23 women with evidence of axillary adenopathy at breast imaging after recent COVID-19 vaccination, with 13% having symptoms, 43% undergoing screening, and 43% undergoing diagnostic imaging for other reasons. Radiologist familiarity and evidence-based guidelines are necessary to prevent unnecessary follow-up imaging and biopsies for reactive adenopathy after COVID-19 vaccination.

AMERICAN JOURNAL OF ROENTGENOLOGY (2021)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

Mitigating the Impact of Coronavirus Disease (COVID-19) Vaccinations on Patients Undergoing Breast Imaging Examinations: A Pragmatic Approach

Constance D. Lehman et al.

Summary: Reports of patients with axillary adenopathy identified on breast imaging after COVID-19 vaccination are increasing. A pragmatic management approach based on clinical presentation, vaccination delivery, and imaging findings is proposed to reduce patient anxiety, provider burden, and costs of unnecessary evaluation of enlarged nodes. Recommendations aim to avoid delays in vaccinations and breast cancer screening during the pandemic, aligning with the ACR BI-RADS Atlas.

AMERICAN JOURNAL OF ROENTGENOLOGY (2021)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

Multidisciplinary Recommendations Regarding Post-Vaccine Adenopathy and Radiologic Imaging: Radiology Scientific Expert Panel

Anton S. Becker et al.

Summary: Vaccination-associated adenopathy is a common imaging finding after COVID-19 vaccination, which may be mistaken for malignant nodal involvement in patients with cancer. Routine imaging should be scheduled at least 6 weeks after vaccination, while clinically indicated imaging should not be delayed.

RADIOLOGY (2021)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

Unilateral axillary Adenopathy in the setting of COVID-19 vaccine

Nishi Mehta et al.

Summary: With the FDA approval and rollout of Pfizer-BioNTech and Moderna COVID-19 vaccines, radiologists should consider recent COVID-19 vaccination history when diagnosing patients with unilateral axillary adenopathy. Differential diagnosis should include hyperplastic axillary nodes induced by COVID-19 vaccination, and short-term follow-up is recommended over immediate axillary lymph node biopsies.

CLINICAL IMAGING (2021)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging